Grupo Financiero Galicia SA(GGAL)
$29.75+0.71 (+2.44%)
GGAL
Grupo Financiero Galicia SA financials statements
$29.75
At close:+0.71 (+2.44%)
Want to see GGAL full AI Analyst Report?
Grupo Financiero Galicia SA (GGAL) Financial Statements
1,066 Followers
Grupo Financiero Galicia SA Financial Overview
Grupo Financiero Galicia SA's market cap is currently ARS5.20B. The company's EPS TTM is ARS1356.90; its P/E ratio is 46.17; and it has a dividend yield of 5.55%. Grupo Financiero Galicia SA has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ARS 12.42T | ARS 10.63T | ARS 13.89T | ARS 8.52T | ARS 2.86T |
| Gross Profit | ARS 5.67T | ARS 6.66T | ARS 6.88T | ARS 4.33T | ARS 1.63T |
| Operating Income | ARS 303.85B | ARS 2.21T | ARS 1.18T | ARS 444.45B | ARS 288.14B |
| EBITDA | ARS 608.44B | ARS 2.40T | ARS 1.42T | ARS 633.50B | ARS 376.09B |
| Net Income | ARS 212.52B | ARS 1.62T | ARS 734.24B | ARS 329.38B | ARS 188.62B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ARS 9.37T | ARS 3.76T | ARS 2.00T | ARS 627.91B | ARS 462.49B |
| Total Assets | ARS 45.67T | ARS 32.52T | ARS 10.22T | ARS 10.49T | ARS 3.27T |
| Total Debt | ARS 3.60T | ARS 2.16T | ARS 465.73B | ARS 491.26B | ARS 160.31B |
| Net Debt | ARS -5.77T | ARS -203.15B | ARS -1.53T | ARS -902.43B | ARS -302.18B |
| Total Liabilities | ARS 37.91T | ARS 26.45T | ARS 8.20T | ARS 8.59T | ARS 2.68T |
| Stockholders' Equity | ARS 7.76T | ARS 6.06T | ARS 2.02T | ARS 1.90T | ARS 593.09B |
| Cash Flow | |||||
| Free Cash Flow | ARS 40.27B | ARS -2.92T | ARS 6.14T | ARS 1.74T | ARS -302.46B |
| Operating Cash Flow | ARS -1.61T | ARS -2.70T | ARS 6.22T | ARS 1.79T | ARS -281.92B |
| Investing Cash Flow | ARS -12.54T | ARS 939.32B | ARS -178.26B | ARS -137.68B | ARS -17.57B |
| Financing Cash Flow | ARS 873.80B | ARS 413.52B | ARS -500.34B | ARS 83.96B | ARS 51.13B |
Currency in ARS

